Leominster, MA, United States of America

Lisa M Cuff

USPTO Granted Patents = 7 

 

Average Co-Inventor Count = 11.8

ph-index = 4

Forward Citations = 44(Granted Patents)


Company Filing History:


Years Active: 2009-2017

Loading Chart...
Loading Chart...
7 patents (USPTO):

Title: Innovations of Lisa M Cuff in Pharmaceutical Development

Introduction

Lisa M Cuff is a prominent inventor based in Leominster, MA (US), known for her significant contributions to the field of pharmaceuticals. With a total of seven patents to her name, she has made remarkable strides in developing compounds aimed at treating various medical conditions.

Latest Patents

Among her latest innovations are the 2-acylaminopropoanol-type glucosylceramide synthase inhibitors. These compounds are designed for use in treating polycystic kidney disease and are represented by a specific structural formula. The pharmaceutical compositions she has developed include compounds that can be administered to patients in need of effective treatment for polycystic kidney disease. Additionally, her work addresses conditions such as type 2 diabetes, renal hypertrophy, and hyperplasia associated with diabetic nephropathy, as well as genetic disorders like Tay-Sachs, Gaucher's, and Fabry's disease.

Career Highlights

Lisa M Cuff is currently associated with Genzyme Corporation, where she continues to innovate in the pharmaceutical sector. Her research focuses on methods to decrease plasma TNF-α, lower blood glucose levels, and inhibit glucosylceramide synthase, among other therapeutic strategies.

Collaborations

Throughout her career, Lisa has collaborated with notable colleagues, including Craig S Siegel and Cecilia M Bastos, contributing to a dynamic research environment that fosters innovation.

Conclusion

Lisa M Cuff's work exemplifies the impact of innovative thinking in the pharmaceutical industry. Her patents and research efforts are paving the way for new treatments that can significantly improve patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…